$12 million grant renewal for flu vaccine research

The National Institutes of Health has awarded the Stanford Institute for Immunity, Transplantation and Infection a five-year, $12 million renewal of a grant for the study of how people respond to influenza vaccination.

Mark Davis
Mark Davis. (Image credit: Steve Fisch)

With the renewal, the total amount granted for this project has exceeded $50 million since the first award was made in 2003.

According to MARK DAVIS, director of the institute and professor of microbiology and immunology, the project’s primary goal is to better understand the human immune system, how it varies and why, using new technologies, new ideas and new ways to improve an influenza vaccine that “is so ineffective in many people, especially the elderly, that it is one of the top priorities for improvement.”

Much of the work is being done through Stanford’s Human Immune Monitoring Center, directed by HOLDEN MAECKER, professor of microbiology and immunology. Davis, who holds the Burt and Marion Avery Family Professorship, praised the center as having created “the world’s best high-tech engine of human immune discovery, gathering huge amounts of data from carefully constructed clinical studies and subjecting these data to rigorous analysis.”

The center also received a separate $50 million grant from the Gates Foundation in 2015.

Read the full article on the School of Medicine website.